Edition:
India

Pharmena SA (PHR.WA)

PHR.WA on Warsaw Stock Exchange

5.72PLN
18 Oct 2019
Change (% chg)

-0.34zł (-5.61%)
Prev Close
6.06zł
Open
5.86zł
Day's High
5.86zł
Day's Low
5.68zł
Volume
3,123
Avg. Vol
1,649
52-wk High
9.14zł
52-wk Low
4.90zł

Latest Key Developments (Source: Significant Developments)

Pharmena Gets Positive Test Results On 1-MNA Drug In NASH Indication
Wednesday, 10 Jul 2019 

July 10 (Reuters) - Pharmena SA ::SAYS GETS POSITIVE RESULTS FROM PRECLINICAL TESTS ON ANIMAL MODEL FROM ITS US-BASED UNIT CORTRIA CORPORATION.PRE-CLINICAL TESTS REGARDED 1-MNA DRUG IN NASH INDICATION.  Full Article

Pharmena Introduces New Supplement, Menavitin Senior
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Pharmena SA ::SAYS IS TO INTRODUCE NEW SUPPLEMENT, MENAVITIN SENIOR, FROM MENAVITIN LINE.  Full Article

Pharmena Launches Sales Of Two More Diet Supplements From Menavitin Line In Poland
Thursday, 13 Jun 2019 

June 13 (Reuters) - Pharmena SA ::SAYS LAUNCHES SALES OF TWO MORE DIET SUPPLEMENTS FROM MENAVITIN LINE IN POLAND.SAYS THESE ARE MENAVITIN MEMORY AND MENAVITIN DIABETIX.  Full Article

2.2 Mln E Series Shares Of Pharmena Were Subscribed For At 6 Zlotys/Shr
Thursday, 6 Jun 2019 

June 6 (Reuters) - Pharmena SA ::SAYS 2.2 MILLION E SERIES SHARES WERE SUBSCRIBED FOR AT 6 ZLOTYS PER SHARE.  Full Article

Pharmena Series E Shares To Start Trading At Main Market Of WSE
Thursday, 6 Jun 2019 

June 6 (Reuters) - Pharmena SA ::ITS SERIES E SHARES TO START TRADING AT MAIN MARKET OF WARSAW STOCK EXCHANGE AS OF JUNE 7.  Full Article

Pharmena Launches Sales Of New Batch Of Diet Supplements
Friday, 24 May 2019 

May 24 (Reuters) - Pharmena SA ::LAUNCHES SALES OF MENAVITIN VITAL AND MENAVITIN ENDOTELIO DIET SUPPLEMENTS IN POLAND.SAID LAUNCH IS ONE OF CO'S STRATEGY ELEMENTS TO DISTRIBUTE DIET SUPPLEMENTS CONTAINING 1-MNA PARTICLE IN EUROPEAN MARKETS.IN FORTHCOMING MONTHS CO PLANS LAUNCHING SALES OF SAID SUPPLEMENTS IN GERMANY, AUSTRIA AND SWITZERLAND.  Full Article

Pharmena FY Net Loss Narrows To 0.4 Million Zlotys
Thursday, 21 Mar 2019 

March 21 (Reuters) - Pharmena SA ::FY NET LOSS 0.4 MILLION ZLOTYS VERSUS LOSS OF 2.5 MILLION ZLOTYS YEAR AGO.FY REVENUE 13.0 MILLION ZLOTYS VERSUS 12.5 MILLION ZLOTYS YEAR AGO.  Full Article

Pharmena Plans To Issue Bonds or Take Loan, Sets Issue Price For Series E Shares
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Pharmena SA ::PLANS TO ISSUE BONDS OR TAKE LOAN IN TOTAL AMOUNT OF UP TO 12 MILLION ZLOTYS.POTENTIAL FUNDS WOULD HELP CO TO INTRODUCE TO TRADE ITS DIET SUPPLEMENTS UNTIL IT CAN ISSUE SERIES E SHARES.SETS ISSUE PRICE OF SERIES E SHARES AT 6 ZLOTY PER SHARE.SAYS SERIES E SHARE ISSUE IS SUBJECT TO FINANCIAL REGULATOR'S APPROVAL OF ISSUE PROSPECTUS.  Full Article

Pharmena Resolves To Establish Special Purpose Vehicle In Germany
Tuesday, 10 Jul 2018 

July 10 (Reuters) - PHARMENA SA ::MANAGEMENT RESOLVES TO ESTABLISH SPECIAL PURPOSE VEHICLE IN GERMANY.SPECIAL PURPOSE VEHICLE TO SELL DIETARY SUPPLEMENTS CONTAINING 1-MNA ON THE MARKETS OF GERMANY, AUSTRIA AND SWITZERLAND.CO INFORMED ABOUT EUROPEAN COMMISSION'S AUTHORIZATION FOR 1-MNA AS A NEW FOOD INGREDIENT IN JUNE nFWN1TE075.  Full Article

Pharmena: European Commission Authorizes 1-MNA As New Food Ingredient
Tuesday, 12 Jun 2018 

June 12 (Reuters) - PHARMENA SA ::EUROPEAN COMMISSION AUTHORIZES 1-MNA AS A NEW FOOD INGREDIENT.IN ONE MONTH CO CAN START INTRODUCING DIETARY SUPPLEMENT CONTAINING 1-MNA TO MARKET.  Full Article